MedPath

STUDY OF THE EFFICACY OF KATUKADYA GHAN VATI IN MANAGEMENT OF HYPERTENSION.

Phase 1
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2018/11/016247
Lead Sponsor
carc college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having primary hypertension recently diagnosed.

2) Age : 30 to 70 years.

3) Gender : Irrespective of gender.

4) Stage 1 hypertension i. e. Systolic blood pressure is upto 160 mm of Hg &/or

diastolic blood pressure upto100 mm of Hg.

Exclusion Criteria

1) Hypertension Secondary to Any major Systemic illness.

2) Patient with known case of acute coronary syndrome, cardiomyopathies,

Myocardial infarction, stroke.

3) Pregnant, lactating women & women on oestrogen replacement therapy.

4) Alcohol & drug abusers

5) Accelerated & malignant hypertension

6) Complicated multiple organ failure conditions.

7) Encephalopathy

8) Mentally ill patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of the Katukadya Ghan Vati in uchcha raktdaab i.e. <br/ ><br>essential hypertension.Timepoint: To assess the efficacy of the Katukadya Ghan Vati in uchcha raktdaab i.e. <br/ ><br>essential hypertension in 30days
Secondary Outcome Measures
NameTimeMethod
1)To assess the efficacy of Atenolol in uchcha raktdaab i.e. essential hypertension. <br/ ><br>2) To assess the adverse eventsTimepoint: For one month
© Copyright 2025. All Rights Reserved by MedPath